AstraZeneca PLC (AZN)
160.17
+0.53
(+0.33%)
USD |
NYSE |
Sep 11, 16:00
161.00
+0.83
(+0.52%)
Pre-Market: 04:43
AstraZeneca Market Cap : 496.79B for Sept. 11, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 11, 2026 | 496.79B |
| September 10, 2026 | 495.15B |
| September 09, 2026 | 486.78B |
| September 08, 2026 | 496.39B |
| September 04, 2026 | 504.64B |
| September 03, 2026 | 511.06B |
| September 02, 2026 | 501.32B |
| September 01, 2026 | 503.93B |
| August 31, 2026 | 502.87B |
| August 28, 2026 | 504.64B |
| August 27, 2026 | 510.29B |
| August 26, 2026 | 515.71B |
| August 25, 2026 | 526.23B |
| August 24, 2026 | 517.08B |
| August 21, 2026 | 514.81B |
| August 20, 2026 | 510.19B |
| August 19, 2026 | 511.62B |
| August 18, 2026 | 496.58B |
| August 17, 2026 | 486.62B |
| August 14, 2026 | 485.26B |
| August 13, 2026 | 487.71B |
| August 12, 2026 | 491.61B |
| August 11, 2026 | 492.39B |
| August 10, 2026 | 502.19B |
| August 07, 2026 | 500.67B |
| Date | Value |
|---|---|
| August 06, 2026 | 499.59B |
| August 05, 2026 | 500.92B |
| August 04, 2026 | 482.68B |
| August 03, 2026 | 489.97B |
| July 31, 2026 | 526.17B |
| July 30, 2026 | 531.44B |
| July 29, 2026 | 537.52B |
| July 28, 2026 | 534.98B |
| July 27, 2026 | 526.17B |
| July 24, 2026 | 524.99B |
| July 23, 2026 | 521.92B |
| July 22, 2026 | 526.45B |
| July 21, 2026 | 525.24B |
| July 20, 2026 | 510.29B |
| July 17, 2026 | 523.87B |
| July 16, 2026 | 525.08B |
| July 15, 2026 | 522.23B |
| July 14, 2026 | 510.22B |
| July 13, 2026 | 525.64B |
| July 10, 2026 | 532.28B |
| July 09, 2026 | 553.62B |
| July 08, 2026 | 587.08B |
| July 07, 2026 | 598.99B |
| July 06, 2026 | 589.81B |
| July 02, 2026 | 605.29B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| GSK Plc | 97.35B |
| Johnson & Johnson | 639.58B |
| Eli Lilly & Co. | 1.050T |
| Merck & Co., Inc. | 355.31B |
| Novo Nordisk A/S | 144.11B |
Market Cap Related Metrics
| PE Ratio | 48.10 |
| PS Ratio | 8.269 |
| PEG Ratio | 1.414 |
| Price to Book Value | 10.50 |
| Price to Free Cash Flow | 62.11 |
| Price | 160.17 |
| Earnings Yield | 2.08% |
| PEGY Ratio | 1.336 |
| Operating PE Ratio | 35.60 |
| Normalized PE Ratio | 47.55 |